Fundraising FoxENNODC
1 known investors
Find your way into ENNODC
Sign up to see every warm intro you have to ENNODC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ENNODC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EnnoDC is a clinical-stage biotech developing a class of immunotherapy antibodies called Dendritic Cell (DC) engagers, which prime antigens and activate dendritic cells to trigger an immune response against cancer and viral infections. Its pipeline includes five antibody candidates, with programs in HPV16+ oropharyngeal and prostate cancer following early clinical work in HIV and COVID-19.
Investors · 1
Frequently asked questions
- What does ENNODC do?
- EnnoDC is a clinical-stage biotech developing a class of immunotherapy antibodies called Dendritic Cell (DC) engagers, which prime antigens and activate dendritic cells to trigger an immune response against cancer and viral infections. Its pipeline includes five antibody candidates, with programs in HPV16+ oropharyngeal and prostate cancer following early clinical work in HIV and COVID-19.
- Who are ENNODC's investors?
- ENNODC's investors include In-Q-Tel.